Todd Carter - Sep 19, 2022 Form 3 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Chief Scientific Officer
Signature
/s/ Robert Hesslein, as Attorney-in-Fact for Todd Carter
Stock symbol
VYGR
Transactions as of
Sep 19, 2022
Transactions value $
$0
Form type
3
Date filed
9/21/2022, 04:39 PM
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VYGR Common Stock 36.2K Sep 19, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 22K $14.14 Direct F2
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 11K $12.13 Direct F3
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 11.3K $19.36 Direct F4
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 15K $11.53 Direct F5
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 10K $9.10 Direct F6
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 13.5K $12.96 Direct F7
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 11.1K $7.33 Direct F8
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 50K $2.85 Direct F9
holding VYGR Stock Option (Right to Buy) Sep 19, 2022 Common Stock 30K $6.20 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock issuable under restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "2015 Plan") that vest periodically. Each RSU represents the right to receive one share of common stock upon vesting.
F2 This stock option was issued pursuant to the 2015 Plan and has vested in full.
F3 This stock option was issued pursuant to the 2015 Plan and has vested in full.
F4 This stock option was issued pursuant to the 2015 Plan and has vested in full.
F5 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, November 29, 2018. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F6 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, January 11, 2019. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F7 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, February 10, 2020. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F8 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, February 16, 2021. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F9 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, January 13, 2022. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F10 This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, March 14, 2022. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Limited Power of Attorney